alexa Soluble MICB serum levels correlate with disease stage and survival rate in patients with oral squamous cell carcinoma.


Immunological Disorders & Immunotherapy

Author(s): Tamaki S, Kawakami M, Ishitani A, Kawashima W, Kasuda S,

Abstract Share this page

Abstract BACKGROUND: Expression of ligands of natural killer group 2D (NKG2D) immunoreceptors, such as major histocompatibility complex class I-related chain A/B (MICA/B), has been proposed to play an important role in tumour immunosurveillance. Soluble forms of MICA/B are increased in sera of cancer patients and are postulated to impair antitumour immune response by downregulating expression of NKG2D immunoreceptors. Serum levels of soluble MICA have been shown to be of diagnostic significance in malignant diseases. AIMS: The potential of soluble MICB (sMICB) as a marker for oral squamous cell carcinoma (OSCC) was investigated. RESULTS: sMICB levels did not differ significantly from those in normal control individuals. However, the findings indicate that sMICB levels are significantly increased in stage IV OSCC and high sMICB levels are significantly associated with decreased survival rates in patients.
This article was published in Anticancer Res and referenced in Immunological Disorders & Immunotherapy

Relevant Expert PPTs

Recommended Conferences

  • 7th World Congress on Immunology
    September 11-12, 2017 Amsterdam, Netherlands
  • 3rd International Congress on Neuroimmunology and Therapeutics
    November 2-3, 2017 Atlanta, Georgia, USA
  • 2nd International Conference on Autoimmunity
    November 06-07, 2017 Frankfurt, Germany
  • World Immunology Congress
    Dec 14-15, 2017 Dubai, UAE

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version